AI companies run virtual drug trials, aim to improve success of human studies

By Deena Beasley Oct 7 (Reuters) - Novartis’ experimental del-desiran for a rare type of muscular dystrophy was expected to ...

Focus: AI companies run virtual drug trials, aim to improve success of human studies

Novartis’ experimental del-desiran for a rare type of muscular dystrophy was expected to be a winner, with the Swiss company's CEO predicting annual peak sales of $5 billion. When a late-stage trial ...